Ahead of merger with Pfizer’s generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
South Africa in the news: Ahead of merger with Pfizer’s generic unit, Mylan makes 7M+ purchase for European thrombosis portfolio: Mylan is increasing its presence in Europe with a high-dollar acquisition of a blood clot portfolio. The generic drugmaker is paying more than three-quarters of a billion dollars to gobble up Aspen …: “South Africa” …
